[en] Background: Alterations to the gut microbiome have been linked to multiple chronic diseases. However, the drivers of such changes remain largely unknown. The oral cavity acts as a major route of exposure to exogenous factors including pathogens, and processes therein may affect the communities in the subsequent compartments of the gastrointestinal tract. Here, we perform strain‑resolved, integrated meta‑genomic, transcriptomic, and proteomic analyses of paired saliva and stool samples collected from 35 individuals from eight families with multiple cases of type 1 diabetes mellitus (T1DM).
Results: We identified distinct oral microbiota mostly reflecting competition between streptococcal species. More specifically, we found a decreased abundance of the commensal Streptococcus salivarius in the oral cavity of T1DM individuals, which is linked to its apparent competition with the pathobiont Streptococcus mutans. The decrease in S. salivarius in the oral cavity was also associated with its decrease in the gut as well as higher abundances in facultative anaerobes including Enterobacteria. In addition, we found evidence of gut inflammation in T1DM as reflected in the expression profiles of the Enterobacteria as well as in the human gut proteome. Finally, we were able to follow transmitted strain‑variants from the oral cavity to the gut at the individual omic levels, highlighting not only the transfer, but also the activity of the transmitted taxa along the gastrointestinal tract.
Conclusions: Alterations of the oral microbiome in the context of T1DM impact the microbial communities in the lower gut, in particular through the reduction of “mouth‑to‑gut” transfer of Streptococcus salivarius. Our results indicate that the observed oral‑cavity‑driven gut microbiome changes may contribute towards the inflammatory processes involved in T1DM. Through the integration of multi‑omic analyses, we resolve strain‑variant “mouth‑to‑gut” transfer in a disease context.
Research center :
- Luxembourg Centre for Systems Biomedicine (LCSB): Eco-Systems Biology (Wilmes Group) - Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group)
Disciplines :
Microbiology
Author, co-author :
Kunath, Benoît ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Systems Ecology
Hickl, Oskar ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Bioinformatics Core
Teixeira Queiros, Pedro ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Systems Ecology
Martin-Gallausiaux, Camille ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Systems Ecology
Lebrun, Laura ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Systems Ecology
Halder, Rashi ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Scientific Central Services
Laczny, Cedric Christian ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Systems Ecology
Schmidt, Thomas Sebastian; European Molecular Biology Laboratory, Heidelberg, Germany > Structural and Computational Biology Unit
Hayward, Matthew; European Molecular Biology Laboratory, Heidelberg, Germany > Structural and Computational Biology Unit
Becher, Dorte; Institute of Microbiology, University of Greifswald, Greifswald, Germany
Heintz-Buschart, Anna; Swammerdam Institute for Life Sciences, University of Amsterdam, The Netherlands
Gilbert JA, et al. Current understanding of the human microbiome. Nat Med. 2018;24:392–400. DOI: 10.1038/nm.4517
Karczewski J, Poniedziałek B, Adamski Z, Rzymski P. The effects of the microbiota on the host immune system. Autoimmunity. 2014;47:494–504. DOI: 10.3109/08916934.2014.938322
Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30:492–506. DOI: 10.1038/s41422-020-0332-7
Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat Commun. 2017;8:1784. DOI: 10.1038/s41467-017-01973-8
Gilbert JA, et al. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature. 2016;535:94–103. DOI: 10.1038/nature18850
Wen L, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature. 2008;455:1109–13. DOI: 10.1038/nature07336
Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336:1268–73. DOI: 10.1126/science.1223490
Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535:75–84. DOI: 10.1038/nature18848
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–14. DOI: 10.1038/nature11234
Lloyd-Price J, et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature. 2017;550:61–6. DOI: 10.1038/nature23889
Van Rossum T, Ferretti P, Maistrenko OM, Bork P. Diversity within species: interpreting strains in microbiomes. Nat Rev Microbiol. 2020;18:491–506. DOI: 10.1038/s41579-020-0368-1
Caro-Quintero A, Konstantinidis KT. Bacterial species may exist, metagenomics reveal. Environ Microbiol. 2012;14:347–55. DOI: 10.1111/j.1462-2920.2011.02668.x
Denef VJ. Peering into the genetic makeup of natural microbial populations using metagenomics. In: Polz MF, Rajora OP, editors. Population genomics: microorganisms. New York City: Springer; 2019. p. 49–75.
Zojer M, et al. Variant profiling of evolving prokaryotic populations. PeerJ. 2017;5:e2997. DOI: 10.7717/peerj.2997
Wang Z, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57–63. DOI: 10.1038/nature09922
Frank DN, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104:13780–5. DOI: 10.1073/pnas.0706625104
Turnbaugh PJ, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–31. DOI: 10.1038/nature05414
Garrett WS. Cancer and the microbiota. Science. 2015;348:80–6. DOI: 10.1126/science.aaa4972
Spielman LJ, Gibson DL, Klegeris A. Unhealthy gut, unhealthy brain: the role of the intestinal microbiota in neurodegenerative diseases. Neurochem Int. 2018;120:149–63. DOI: 10.1016/j.neuint.2018.08.005
Zhang X, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21:895–905. DOI: 10.1038/nm.3914
Paun A, Yau C, Danska JS. The influence of the microbiome on type 1 diabetes. J Immunol. 2017;198:590–5. DOI: 10.4049/jimmunol.1601519
Sharma S, Tripathi P. Gut microbiome and type 2 diabetes: where we are and where to go? J Nutr Biochem. 2019;63:101–8. DOI: 10.1016/j.jnutbio.2018.10.003
Diaz-Valencia PA, Bougnères P, Valleron A-J. Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health. 2015;15:255. DOI: 10.1186/s12889-015-1591-y
Dabelea D. The accelerating epidemic of childhood diabetes. Lancet. 2009;373:1999–2000. DOI: 10.1016/S0140-6736(09)60874-6
Patterson CC, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009;373:2027–33. DOI: 10.1016/S0140-6736(09)60568-7
Mobasseri M, et al. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10:98–115. DOI: 10.34172/hpp.2020.18
Rewers M, Ludvigsson J. Environmental risk factors for type 1 diabetes. Lancet. 2016;387:2340–8. DOI: 10.1016/S0140-6736(16)30507-4
Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16:341–52. DOI: 10.1038/nri.2016.42
Brown CT, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE. 2011;6:e25792. DOI: 10.1371/journal.pone.0025792
Alkanani AK, et al. Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes. 2015;64:3510–20. DOI: 10.2337/db14-1847
Giongo A, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011;5:82–91. DOI: 10.1038/ismej.2010.92
Jamshidi P, et al. Is there any association between gut microbiota and type 1 diabetes? A systematic review. Gut Pathog. 2019;11:49. DOI: 10.1186/s13099-019-0332-7
Xiao J, Fiscella KA, Gill SR. Oral microbiome: possible harbinger for children’s health. Int J Oral Sci. 2020;12:12. DOI: 10.1038/s41368-020-0082-x
Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15:30–44. DOI: 10.1038/nri3785
Cullinan MP, Seymour GJ. Periodontal disease and systemic illness: will the evidence ever be enough? Periodontol 2000. 2013;62:271–86. DOI: 10.1111/prd.12007
Song I-S, et al. Severe periodontitis is associated with insulin resistance in non-abdominal obese adults. J Clin Endocrinol Metab. 2016;101:4251–9. DOI: 10.1210/jc.2016-2061
Borgnakke WS, Ylöstalo PV, Taylor GW, Genco RJ. Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence. J Periodontol. 2013;84:S135–52. DOI: 10.1902/jop.2013.1340013
Segata N, et al. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol. 2012;13:R42. DOI: 10.1186/gb-2012-13-6-r42
Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol. 2005;96:94–102. DOI: 10.1111/j.1742-7843.2005.pto960202.x
Ding T, Schloss PD. Dynamics and associations of microbial community types across the human body. Nature. 2014;509:357–60. DOI: 10.1038/nature13178
Schmidt TS, et al. Extensive transmission of microbes along the gastrointestinal tract. Elife. 2019;8:e42693. DOI: 10.7554/eLife.42693
Naing C, Mak JW. Salivary glucose in monitoring glycaemia in patients with type 1 diabetes mellitus: a systematic review. J Diabetes Metab Disord. 2017;16:2. DOI: 10.1186/s40200-017-0287-5
Seethalakshmi C, Reddy RCJ, Asifa N, Prabhu S. Correlation of salivary pH, incidence of dental caries and periodontal status in diabetes mellitus patients: a cross-sectional study. J Clin Diagn Res. 2016;10:ZC12–4.
Gandara BK, Morton TH. Non-periodontal oral manifestations of diabetes: a framework for medical care providers. Diabetes Spectr. 2011;24:199–205. DOI: 10.2337/diaspect.24.4.199
de Groot PF, et al. Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study. PLoS ONE. 2017;12:e0188475. DOI: 10.1371/journal.pone.0188475
Heintz-Buschart A, et al. Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nat Microbiol. 2016;2:16180. DOI: 10.1038/nmicrobiol.2016.180
Roume H, et al. A biomolecular isolation framework for eco-systems biology. ISME J. 2013;7:110–21. DOI: 10.1038/ismej.2012.72
Kroniger T, et al. Proteome analysis of the Gram-positive fish pathogen Renibacterium salmoninarum reveals putative role of membrane vesicles in virulence. Res Square. 2021. https://doi.org/10.21203/rs.3.rs-744942/v1.
Narayanasamy S, et al. IMP: a pipeline for reproducible reference-independent integrated metagenomic and metatranscriptomic analyses. Genome Biol. 2016;17:260. DOI: 10.1186/s13059-016-1116-8
Li D, Liu C-M, Luo R, Sadakane K, Lam T-W. MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics. 2015;31:1674–6. DOI: 10.1093/bioinformatics/btv033
Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–30. DOI: 10.1093/bioinformatics/btt656
Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44:D457–62. DOI: 10.1093/nar/gkv1070
El-Gebali S, et al. The Pfam protein families database in 2019. Nucleic Acids Res. 2019;47:D427–32. DOI: 10.1093/nar/gky995
Gibson MK, Forsberg KJ, Dantas G. Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology. ISME J. 2015;9:207–16. DOI: 10.1038/ismej.2014.106
Zhang H, et al. dbCAN2: a meta server for automated carbohydrate-active enzyme annotation. Nucleic Acids Res. 2018;46:W95–101. DOI: 10.1093/nar/gky418
Burstein D, et al. New CRISPR-Cas systems from uncultivated microbes. Nature. 2017;542:237–41. DOI: 10.1038/nature21059
Luo H, et al. DEG 15, an update of the Database of Essential Genes that includes built-in analysis tools. Nucleic Acids Res. 2021;49:D677–86. DOI: 10.1093/nar/gkaa917
Milanese A, et al. Microbial abundance, activity and population genomic profiling with mOTUs2. Nat Commun. 2019;10:1014. DOI: 10.1038/s41467-019-08844-4
Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20:257. DOI: 10.1186/s13059-019-1891-0
Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60. DOI: 10.1093/bioinformatics/btp324
Li H. Improving SNP discovery by base alignment quality. Bioinformatics. 2011;27:1157–8. DOI: 10.1093/bioinformatics/btr076
Li H, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9. DOI: 10.1093/bioinformatics/btp352
Hulstaert N, et al. ThermoRawFileParser: modular, scalable, and cross-platform RAW file conversion. J Proteome Res. 2020;19:537–42. DOI: 10.1021/acs.jproteome.9b00328
Chambers MC, et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol. 2012;30:918–20. DOI: 10.1038/nbt.2377
Shen W, Le S, Li Y, Hu F. SeqKit: a cross-platform and ultrafast toolkit for FASTA/Q file manipulation. PLoS ONE. 2016;11:e0163962. DOI: 10.1371/journal.pone.0163962
Guo X, et al. Sipros Ensemble improves database searching and filtering for complex metaproteomics. Bioinformatics. 2018;34:795–802. DOI: 10.1093/bioinformatics/btx601
Simpson EH. Measurement of diversity. Nature. 1949;163:688. DOI: 10.1038/163688a0
Kembel SW, et al. Picante: R tools for integrating phylogenies and ecology. Bioinformatics. 2010;26:1463–4. DOI: 10.1093/bioinformatics/btq166
Dixon P. VEGAN, a package of R functions for community ecology. J Veg Sci. 2003;14:927–30. DOI: 10.1111/j.1654-1103.2003.tb02228.x
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. DOI: 10.1186/s13059-014-0550-8
Abranches J, et al. Biology of oral Streptococci. Microbiol Spectr. 2018;6(5):6–5. DOI: 10.1128/microbiolspec.GPP3-0042-2018
Nes IF, Diep DB, Holo H. Bacteriocin diversity in Streptococcus and Enterococcus. J Bacteriol. 2007;189:1189–98. DOI: 10.1128/JB.01254-06
Mignolet J, et al. Circuitry rewiring directly couples competence to predation in the gut dweller Streptococcus salivarius. Cell Rep. 2018;22:1627–38. DOI: 10.1016/j.celrep.2018.01.055
Hibbing ME, Fuqua C, Parsek MR, Peterson SB. Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol. 2010;8:15–25. DOI: 10.1038/nrmicro2259
Dedrick S, et al. The role of gut microbiota and environmental factors in type 1 diabetes pathogenesis. Front Endocrinol. 2020;11:78. DOI: 10.3389/fendo.2020.00078
Babatzia A, et al. Clinical and microbial oral health status in children and adolescents with type 1 diabetes mellitus. Int Dent J. 2020;70:136–44. DOI: 10.1111/idj.12530
Garnett JA, et al. Structural insight into the role of Streptococcus parasanguinis Fap1 within oral biofilm formation. Biochem Biophys Res Commun. 2012;417:421–6. DOI: 10.1016/j.bbrc.2011.11.131
Takahashi N, Saito K, Schachtele CF, Yamada T. Acid tolerance and acid-neutralizing activity of Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum. Oral Microbiol Immunol. 1997;12:323–8. DOI: 10.1111/j.1399-302X.1997.tb00733.x
Takahashi N. Oral microbiome metabolism: from ‘who are they?’ to ‘what are they doing?’ J Dent Res. 2015;94:1628–37. DOI: 10.1177/0022034515606045
Lemos JA, et al. The biology of Streptococcus mutans. Microbiol Spectr. 2019;7. 10.1128/microbiolspec.GPP3-0051-2018.
Matsui R, Cvitkovitch D. Acid tolerance mechanisms utilized by Streptococcus mutans. Future Microbiol. 2010;5:403–17. DOI: 10.2217/fmb.09.129
Liu Y-L, Nascimento M, Burne RA. Progress toward understanding the contribution of alkali generation in dental biofilms to inhibition of dental caries. Int J Oral Sci. 2012;4:135–40. DOI: 10.1038/ijos.2012.54
Wirawan RE, Swanson KM, Kleffmann T, Jack RW, Tagg JR. Uberolysin: a novel cyclic bacteriocin produced by Streptococcus uberis. Microbiology. 2007;153:1619–30. DOI: 10.1099/mic.0.2006/005967-0
Gabrielsen C, Brede DA, Nes IF, Diep DB. Circular bacteriocins: biosynthesis and mode of action. Appl Environ Microbiol. 2014;80:6854–62. DOI: 10.1128/AEM.02284-14
Kaci G, et al. Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract. Appl Environ Microbiol. 2014;80:928–34. DOI: 10.1128/AEM.03133-13
Villmones HC, et al. Species level description of the human ileal bacterial microbiota. Sci Rep. 2018;8:4736. DOI: 10.1038/s41598-018-23198-5
Couvigny B, et al. Commensal Streptococcus salivarius modulates PPARγ transcriptional activity in human intestinal epithelial cells. PLoS ONE. 2015;10:e0125371. DOI: 10.1371/journal.pone.0125371
Cosseau C, et al. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun. 2008;76:4163–75. DOI: 10.1128/IAI.00188-08
Kaci G, et al. Inhibition of the NF-kappaB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius. Appl Environ Microbiol. 2011;77:4681–4. DOI: 10.1128/AEM.03021-10
Winter SE, Bäumler AJ. Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes. 2014;5:71–3. DOI: 10.4161/gmic.27129
Brenner DJ, Farmer JJ III. Enterobacteriaceae. In: Bergey’s manual of systematics of archaea and bacteria. 2015. p. 1–24. 10.1002/9781118960608.fbm00222. DOI: 10.1002/9781118960608.fbm00222
Zeng MY, Inohara N, Nuñez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2017;10:18–26. DOI: 10.1038/mi.2016.75
Soyucen E, et al. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatr Int. 2014;56:336–43. DOI: 10.1111/ped.12243
Zhang X-S, et al. Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity. Elife. 2018;7:e37816. DOI: 10.7554/eLife.37816
Campbell-Thompson M, Rodriguez-Calvo T, Battaglia M. Abnormalities of the exocrine pancreas in type 1 diabetes. Curr Diab Rep. 2015;15:79. DOI: 10.1007/s11892-015-0653-y
Kaetzel CS. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev. 2005;206:83–99. DOI: 10.1111/j.0105-2896.2005.00278.x
Kaetzel CS, Robinson JK, Chintalacharuvu KR, Vaerman JP, Lamm ME. The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc Natl Acad Sci U S A. 1991;88:8796–800. DOI: 10.1073/pnas.88.19.8796
Moschen AR, Adolph TE, Gerner RR, Wieser V, Tilg H. Lipocalin-2: a master mediator of intestinal and metabolic inflammation. Trends Endocrinol Metab. 2017;28:388–97. DOI: 10.1016/j.tem.2017.01.003
Guo H, et al. Lipocalin 2, a regulator of retinoid homeostasis and retinoid-mediated thermogenic activation in adipose tissue. J Biol Chem. 2016;291:11216–29. DOI: 10.1074/jbc.M115.711556
Bhusal A, Rahman MH, Lee I-K, Suk K. Role of hippocampal lipocalin-2 in experimental diabetic encephalopathy. Front Endocrinol. 2019;10:25. DOI: 10.3389/fendo.2019.00025
Arellano-Buendía AS, et al. Urinary excretion of neutrophil gelatinase-associated lipocalin in diabetic rats. Oxid Med Cell Longev. 2014;2014:961326. DOI: 10.1155/2014/961326
Legrand D, et al. Lactoferrin structure and functions. Adv Exp Med Biol. 2008;606:163–94. DOI: 10.1007/978-0-387-74087-4_6
Akiyama Y, et al. A lactoferrin-receptor, intelectin 1, affects uptake, sub-cellular localization and release of immunochemically detectable lactoferrin by intestinal epithelial Caco-2 cells. J Biochem. 2013;154:437–48. DOI: 10.1093/jb/mvt073
Bertuccini L, et al. Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn’s disease. Dig Liver Dis. 2014;46:496–504. DOI: 10.1016/j.dld.2014.02.009
Dewhirst FE, et al. The human oral microbiome. J Bacteriol. 2010;192:5002–17. DOI: 10.1128/JB.00542-10
Zoetendal EG, et al. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 2012;6:1415–26. DOI: 10.1038/ismej.2011.212
Friedman ES, et al. Microbes vs. chemistry in the origin of the anaerobic gut lumen. Proc Natl Acad Sci U S A. 2018;115:4170–5. DOI: 10.1073/pnas.1718635115
Perez-Riverol Y, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442–50. DOI: 10.1093/nar/gky1106
